Use of liposomal nanoformulations in antileishmania therapy: challenges and perspectives

American tegumentary leishmaniasis in Brazil: a critical review of the current therapeutic approach with systemic meglumine antimoniate and short-term possibilities for an alternative treatment

(2019) Sílvia H. Carvalho et al.   TROPICAL MEDICINE & INTERNATIONAL HEALTH

Liposomal delivery of natural product: A promising approach in health research

(2019) Mohammad Rezaul Islam Shishir et al.   TRENDS IN FOOD SCIENCE & TECHNOLOGY

The activity of encapsulated meglumine antimoniate in stearylamine-bearing liposomes against cutaneous leishmaniasis in BALB/c mice

(2019) Seyedeh Alia Moosavian et al.   EXPERIMENTAL PARASITOLOGY

Development of topical liposomes containing miltefosine for the treatment of Leishmania major infection in susceptible BALB/c mice

(2019) Zahra Kavian et al.   ACTA TROPICA

Recent advances in amphotericin B delivery strategies for the treatment of leishmaniases

(2019) Juliane S. Lanza et al.   Expert Opinion on Drug Delivery

Topical treatment of cutaneous leishmaniasis with novel amphotericin B-miltefosine co-incorporated second generation ultra-deformable liposomes

(2019) M. Junaid Dar et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Pharmacokinetic of meglumine antimoniate encapsulated in phosphatidylserine-liposomes in mice model: A candidate formulation for visceral leishmaniasis

(2018) Samanta Etel Treiger Borborema et al.   BIOMEDICINE & PHARMACOTHERAPY

Hepatic fibropoiesis in dogs naturally infected with Leishmania (Leishmania) infantum treated with liposome-encapsulated meglumine antimoniate and allopurinol

(2018) R.S. Castro et al.   VETERINARY PARASITOLOGY

Comparative efficacy, toxicity and biodistribution of the liposomal amphotericin B formulations Fungisome ® and AmBisome ® in murine cutaneous leishmaniasis

(2018) Gert-Jan Wijnant et al.   International Journal for Parasitology-Drugs and Drug Resistance

Nanoliposomes: Synthesis methods and applications in cosmetics

(2016) Zohreh Fakhravar et al.   Journal of Cosmetic and Laser Therapy

Antimonial drugs entrapped into phosphatidylserine liposomes: physicochemical evaluation and antileishmanial activity

(2016) Samanta Etel Treiger Borborema et al.   Revista da Sociedade Brasileira de Medicina Tropical

Advances and Challenges of Liposome Assisted Drug Delivery

(2015) Lisa Sercombe et al.   Frontiers in Pharmacology

Cationic Liposomal Sodium Stibogluconate (SSG), a Potent Therapeutic Tool for Treatment of Infection by SSG-Sensitive and -Resistant Leishmania donovani

(2014) Roma Sinha et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Use of topical liposomes containing meglumine antimoniate (Glucantime) for the treatment of L. major lesion in BALB/c mice

(2014) S.A. Moosavian Kalat et al.   EXPERIMENTAL PARASITOLOGY

Mixed formulation of conventional and pegylated liposomes as a novel drug delivery strategy for improved treatment of visceral leishmaniasis

(2014) Erly G Azevedo et al.   Expert Opinion on Drug Delivery

Nanotechnology for Diagnosis and Treatment of Infectious Diseases

(2014) Muhammad Qasim et al.   JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY

Liposomes in tissue engineering and regenerative medicine

(2014) N. Monteiro et al.   Journal of the Royal Society Interface

Association of Liposome-Encapsulated Trivalent Antimonial with Ascorbic Acid: An Effective and Safe Strategy in the Treatment of Experimental Visceral Leishmaniasis

(2014) Renata A. O. Castro et al.   PLoS One

Mechanisms of cellular invasion by intracellular parasites

(2013) Dawn M. Walker et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Leishmanicidal activity of amphotericin B encapsulated in PLGA–DMSA nanoparticles to treat cutaneous leishmaniasis in C57BL/6 mice

(2013) Ricardo Fontoura de Carvalho et al.   EXPERIMENTAL PARASITOLOGY

Association of water extract of green propolis and liposomal meglumine antimoniate in the treatment of experimental visceral leishmaniasis

(2013) Flávia M. Ferreira et al.   PARASITOLOGY RESEARCH

Liposome: classification, preparation, and applications

(2013) Abolfazl Akbarzadeh et al.   Nanoscale Research Letters

Colloidal, in vitro and in vivo anti-leishmanial properties of transfersomes containing paromomycin sulfate in susceptible BALB/c mice

(2012) Neda Bavarsad et al.   ACTA TROPICA

Efficacy of Combined Therapy with Liposome-Encapsulated Meglumine Antimoniate and Allopurinol in Treatment of Canine Visceral Leishmaniasis

(2012) Sydnei M. da Silva et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Uptake and antileishmanial activity of meglumine antimoniate-containing liposomes in Leishmania (Leishmania) major-infected macrophages

(2011) Samanta Etel Treiger Borborema et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Nanonization strategies for poorly water-soluble drugs

(2010) Huabing Chen et al.   DRUG DISCOVERY TODAY

Topical delivery andin vivoantileishmanial activity of paromomycin-loaded liposomes for treatment of cutaneous leishmaniasis

(2010) Guilherme Carneiro et al.   JOURNAL OF LIPOSOME RESEARCH

Identification of genetic markers in Sodium Antimony Gluconate (SAG) sensitive and resistant Indian clinical isolates of Leishmania donovani through amplified fragment length polymorphism (AFLP)

(2009) Awanish Kumar et al.   ACTA TROPICA

Reduced Tissue Parasitic Load and Infectivity to Sand Flies in Dogs Naturally Infected by Leishmania (Leishmania) chagasi following Treatment with a Liposome Formulation of Meglumine Antimoniate

(2008) R. R. Ribeiro et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Prolongation of residence time of liposome by surface-modification with mixture of hydrophilic polymers

(2008) Tamer Shehata et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS